Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

Research & Development
: Scientific Presentations

Scientific Presentations

Tonix PTSD Awareness Day - October 26, 2016
Dr. Jonathan Davidson – A Review of Pharmacotherapy for PTSD

Uploaded: Nov 1, 2016
Type: Pdf

Tonix PTSD Awareness Day - October 26, 2016
Dr. Thomas A. Mellman – Focus on Sleep and PTSD Treatment Populations

Uploaded: Nov 1, 2016
Type: Pdf

Tonix PTSD Awareness Day - October 26, 2016
Dr. Gregory Sullivan – Results of the Phase 2 “AtEase Study” in Military-Related PTSD

Uploaded: Nov 1, 2016
Type: Pdf

The AtEase Study: Efficacy and Safety of a Low Dose, Bedtime, Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD

Poster Presentation at the Military Health System Research Symposium (MHSRS) in Kissimmee, FL August 15-18, 2016

Sullivan GM, Gendreau JF, Gendreau RM, Schaberg A, Daugherty BL, Jividen H, Peters A, Peters P, Lederman S. The AtEase Study: Efficacy and Safety of a Low Dose, Bedtime, Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD. Poster session presented at: 2016 Military Health System Research Symposium (MHSRS); 2016 Aug 15-18; Kissimmee, FL.

Uploaded: Aug 15, 2016
Type: Pdf

TNX-102 SL for the Treatment of Fibromyalgia - Comparison of 30% Pain Respondent Analysis with Omeract Draft Composite Responder Endpoint Analyses

Poster Presentation at the European Union League Against Rheumatism 2016 Annual Meeting in London, England June 9, 2016

Gendreau RM, Arnold L, Clauw D, Gendreau J, Vaughn B, Daugherty B, Lederman S. THU0560 TNX-102 SL for the Treatment of Fibromyalgia: Comparison of 30% Pain Responder Analysis with OMERACT Draft Composite Responder Endpoint Analysis. Ann Rheum Dis. 2016; 75(Suppl 2): 394.

Uploaded: Jun 9, 2016
Type: Pdf

A Randomized Placebo-Controlled Multicenter Trial of a Low-Dose Bedtime Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD

Poster Presentation at the American Society of Clinical Psychopharmacology 2016 Annual Meeting in Scottsdale AZ June 1, 2016

Sullivan GM, Gendreau JF, Gendreau RM, Schaberg A, Daugherty BL, Jividen H, Peters A, Peters P, Lederman S. A Randomized Placebo-Controlled Multicenter Trial of a Low-Dose Bedtime Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD. Poster session presented at: American Society of Clinical Psychopharmacology (ASCP) 2016 Annual Meeting. 2016 May 30 - Jun 3; Scottsdale, AZ.

Uploaded: May 31, 2016
Type: Pdf

A Randomized Placebo-Controlled Multicenter Trial of a Low-Dose Bedtime Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD

Oral Presentation at the American Society of Clinical Psychopharmacology, Annual Meeting, Scottsdale AZ May 31, 2016

Sullivan G. A Randomized Placebo-Controlled Multicenter Trial of a Low-Dose Bedtime Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) for the Treatment of Military-Related PTSD. Oral presentation presented at: American Society of Clinical Psychopharmacology (ASCP) 2016 Annual Meeting. 2016 May 30 - Jun 3; Scottsdale, AZ.

Uploaded: May 31, 2016
Type: Pdf

Rapid Sublingual Absorption of Cyclobenzaprine (CBP) with Basifying Agents: Prospect for Bedtime Treatment of Fibromyalgia Syndrome (FM) Presentation Number: LB-026

Poster Presentation at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2016 Annual Meeting in San Diego, CA

Daugherty B, Monti NC, Panzeri V, Marelli R, Magnocavallo E, Reiner G, Lederman S. Rapid Sublingual Absorption of Cyclobenzaprine (CBP) with Basifying Agents: Prospect for Bedtime Treatment of Fibromyalgia Syndrome (FM). Poster session presented at: American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2016 Annual Meeting. 2016 Mar 8-12; San Diego, CA.

Uploaded: Mar 9, 2016
Type: Pdf

Comparative Neuropharmacology of Therapeutic Agents Targeting Posttraumatic Stress Disorder

Poster Presentaiton at the NEI Psychopharmacology Congress in November 2015.

Bruce L. Daugherty, Gregory M. Sullivan, Leland Gershell, Seth Lederman

Uploaded: Nov 13, 2015
Type: Pdf

An Evaluation of the Ef cacy of a Low Dose, Bedtime, Sublingual Formulation of Cyclobenzaprine (TNX-102 SL) in Military-Related PTSD

Poster Presentation at the NEI Psychopharmacology Congress in November 2015.

Gregory M. Sullivan, Judy F. Gendreau, R. Michael Gendreau, Amy Schaberg, Bruce L. Daugherty, Heather Jividen, Ashild Peters, Perry Peters, Seth Lederman

Uploaded: Nov 13, 2015
Type: Pdf